Rani Therapeutics Holdings Class ARANI
13F holders, Q4 2024 (December 31)42holders +11
14new positions
5sold out
1famous investor
$1.37avg. 13F price*
At the end of Q4 2024, 42 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings, up 11 from Q3 2024. 14 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($972K), Nan Fung Group Holdings Ltd ($676K) and Alphabet Inc. ($614K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Rani Therapeutics Holdings Class A
- CUSIP
- 753018100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $968K |
| Exits | 5 | $5.7M |
All 13F filers, Q3 2024 → Q4 2024: 843,647 shares bought and 2,944,120 shares sold, net −2,100,473 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| Vanguard Group Inc. | 0.00% | No change | 709,828 | $972K |
| Nan Fung Group Holdings Ltd | 0.58% | No change | 493,584 | $676K |
| Alphabet Inc. | 0.04% | No change | 448,492 | $614K |
| United Services Automobile Association | 0.01% | No change | 302,743 | $415K |
| Two Sigma Investments, LP | 0.00% | New | 291,381 | $399K |
| Takeda Pharmaceutical Co. Ltd. | 1.05% | No change | 203,190 | $278K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.4% | 171,573 | $235K |
| Kestra Private Wealth Services, LLC | 0.00% | New | 119,620 | $164K |
| Citadel Advisors | 0.00% | Add +342.2% | 118,966 | $163K |
| Two Sigma Advisers, LP | 0.00% | New | 110,163 | $151K |
| Northern Trust Corp. | 0.00% | No change | 105,634 | $145K |
| Bank of America Corp. | 0.00% | Reduce -2.6% | 74,128 | $102K |
| BlackRock, Inc. | 0.00% | No change | 63,583 | $87K |
| Lasry Marc | 0.38% | No change | 62,887 | $86K |
| State Street Corp. | 0.00% | Add +48.5% | 62,442 | $86K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -21.0% | 56,500 | $77K |
| Motco | 0.01% | No change | 48,129 | $66K |
| Insigneo Advisory Services, LLC | 0.01% | New | 47,500 | $65K |
| Virtu Financial LLC | 0.00% | New | 45,404 | $62K |
| King Luther Capital Management Corp. | 0.00% | Reduce -59.3% | 33,000 | $45K |
| Brown Advisory Inc. | 0.00% | No change | 32,911 | $45K |
| Prime Capital Investment Advisors, LLC | 0.00% | Add +136.9% | 27,208 | $37K |
| Janney Montgomery Scott LLC | 0.00% | New | 27,200 | $37K |
| UBS Group AG | 0.00% | Add +49.8% | 23,525 | $32K |
| Lafayette Investments, Inc. | 0.01% | No change | 19,893 | $27K |
| Ground Swell Capital, LLC | 0.05% | New | 17,153 | $24K |
| Stifel Financial Corp. | 0.00% | Reduce -94.6% | 14,684 | $20K |
| XTX Topco Ltd | 0.00% | New | 12,890 | $18K |
| Choreo, LLC | 0.00% | New | 11,813 | $16K |
| Squarepoint Ops LLC | 0.00% | New | 10,863 | $15K |
| Commonwealth Equity Services, LLC | 0.00% | New | 10,409 | $14K |
| Cerity Partners LLC | 0.00% | No change | 10,000 | $14K |
| Islay Capital Management, LLC | 0.01% | No change | 9,611 | $13K |
| SBI Securities Co., Ltd. | 0.00% | — | 7,099 | $10K |
| Morgan Stanley | 0.00% | Add +23.8% | 6,501 | $9K |
| Allworth Financial LP | 0.00% | No change | 3,119 | $5K |
| R Squared Ltd | 0.00% | — | 2,170 | $3K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 2,000 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 1,500 | $2K |
| AlphaMark Advisors, LLC | 0.00% | New | 500 | $1K |
| Stonebridge Financial Group, LLC | 0.00% | — | 100 | $137 |
| JPMorgan Chase & Co. | 0.00% | No change | 71 | $97 |
"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.